Birth defects of blood clotting factors and obstetric complications
https://doi.org/10.30629/0023-2149-2020-98-11-12-729-738
Abstract
The data about clinical signs, laboratory features and obstetrical complications in women with inherited blood coagulation defects are presented in the survey article. Multidisciplinary approach, including hematologist, obstetrician, laboratory technician, anesthesiologist, neonatologist and midwife, is needed in treatment and patient management. The delivery had to be planned in specialized institutions with clinical experience of managing women with birth defects of blood-coagulation factors.
About the Authors
D. Mikovich
Blood Transfusion Institute of Serbia
Czechoslovakia
Czechoslovakia
Belgrade
A. P. Melnikov
The State Budgetary Healthcare Institution of the Moscow Region Moscow Regional Research Institute of Obstetrics and Gynecology
Russian Federation
Russian Federation
101000, Moscow
References
1. Govorka E. Human placenta. Warsaw. Polish State Medical Publishing House. 1970:471. (In Russian).
2. Pike G.N., Bolton-Maggs P.H.B. Factor deficiencies in pregnancy. Haemotol. Oncol. Clin. N. Am. 2011;25(2):359–378.
3. Casini A., Blondon M., Lebreton A., Koegel G., Tintillier V., de Maistre E., Gautier Ph., Biron Ch., Neerman-Arbez M., de Moer-loose Ph. Natural history of patients with congenital dysfibrinoge-nemia. Blood. 2015;125(43):553–561.
4. The obstetric hematology manual Ed by S. Pavord and B. Hunt. Cambridge University Press. New York. 2010.
5. Ozgu-Erdinc A.S., Togrul C., Aktulay A., Buyukkagnici U., Eyi E.G.Y., Erkaya S. Factor XII (Hageman) levels in women with recurrent pregnancy loss. J. of Pregnancy. Vol 214. Article ID 459192, 3 pages DOI: 10.1155/2014/459192.
6. Amri Y., Kallel Ch., Becheur M., Dabboubi R., Elloumi M., Belaaj H., Kammoun S., Messaound T., de Moerloose Ph.. Toumi N. El H. Hypodysfibrinogenemia: a novel abnormal fibrinogen associated with bleeding and thrombotic complications. Clin. Chim. Acta. 2016;460(1):55–62.
7. Bouvier S., Chea M., Ripart S., Hanss M., de Mazancourt Ph., Gris J.Ch. Successful pregnancy under fibrinogen substitution with heparin and aspirin in a woman with dysfibrinogenemia revealed by placenta abruption. Thrombosis and haemostasis. 2018;8;118(11):2006– 2008. DOI: 10.1055/s-0038-1673615. ISSN 0340-6245.
8. Iwaki T, Sandoval-Cooper M.J., Paiva M., Kobayashi T., Plo-plis V.A., Castellino F.J. Fibrinogen stabilizes placental–maternal attachment during embryonic development in the mouse. Am. J. Pa-thol. 2002;160(3):1021–1034.
9. Peyvandi F., Kunicki T., Lillicrap D. Genetic sequence analysis of inherited bleeding diseases. Blood. 2013;122(20):3423–3431.
10. Ebina Y., Ieko M., Naito S., Kobashi G., Deguchi M., Minakami H., Atsumi T., Yamada H. Low levels of plasma protein S, protein C and coagulation factor XII during early pregnancy and adverse pregnancy outcome. Thromb. Haemost. 2015;114(1):65–69.
Review
For citations:
Mikovich D., Melnikov A.P. Birth defects of blood clotting factors and obstetric complications. Clinical Medicine (Russian Journal). 2020;98(11-12):729-738. (In Russ.) https://doi.org/10.30629/0023-2149-2020-98-11-12-729-738
Views:
547
Email this article 